Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Rolf GruetterAwards:
1999 Young Investigator Award Plenary Lectureship
, International Society for Neurochemistry
2011 Fellow
, ESMRMB
2011 Teaching Award
, Section Sciences de la Vie, EPFL
Pierre MagistrettiPierre J. Magistretti is an internationally-recognized neuroscientist who has made significant contributions in the field of brain energy metabolism. His group has discovered some of the cellular and molecular mechanisms that underlie the coupling between neuronal activity and energy consumption by the brain.
This work has considerable ramifications for the understanding of the origin of the signals detected with the current functional brain imaging techniques used in neurological and psychiatric research (see for example Magistretti et al, Science, 283: 496 497, 1999). He is the author of over 100 articles published in peer-reviewed journals.
He has given over 80 invited lectures at international meetings or at universities in Europe and North America, including the 2000 Talairach Lecture at the Functional Mapping of the Human Brain Conference. In November 2000 he has been a Mc Donnel Visiting Scholar at Washington University School of Medicine.
Pierre J. Magistretti is the President-Elect (2002 2004) of the Federation of European Neuroscience Societies (FENS) which has a membership of over 15000 European neuroscientists. He has been first president of the Swiss Society for Neuroscience (1997-1999) and the first Chairman of the Department of Neurosciences of the University of Lausanne (1996 1998).
Pierre J. Magistretti is Professor of Physiology (since 1988) at the University of Lausanne Medical School. He has been Vice-Dean of the University of Lausanne Medical School from 1996 to 2000. Pierre Magistretti, is Director of the Brain Mind Institute at EPFL and Director of the Center for Psychiatric Neuroscience of the University of Lausanne and CHUV. He is also Director of the NCCR SYNAPSY "the synaptic bases of mental diseases".
POSITIONS AND HONORS
MAIN POSITION HELD
1988-2004 Professor of Physiology, University of Lausanne Medical School
1996-2000 Vice-Dean for Preclinical Departments, University of Lausanne Medical School
2001-2004 Chairman, Department of Physiology, University of Lausanne Medical School
2004-present Professor and Director, Center for Psychiatric Neuroscience, Department of Psychiatry, University of Lausanne Medical School and Hospitals (UNIL-CHUV) (Joint appointment with EPFL)
2005-2008 Professor and Co-Director, Brain Mind Institute, Federal Institute of Technology (EPFL), Lausanne (Joint appointment with UNIL-CHUV)
2007-present Chairman of the Scientific Advisory Board of Centre dImagerie Biomédicale (CIBM), an Imaging Consortium of the Universities, University Hospitals of Lausanne and Geneva and of Ecole Polytechnique Fédérale de Lausanne
2008-present Professor and Director, Brain Mind Institute, Federal Institute of Technology (EPFL), Lausanne Joint appointment with UNIL-CHUV)
2010-present Director, National Center for Competence in Research (NCCR)
The synaptic bases of mental diseases of the Swiss National Science Foundation
2010-present Secretary General, International Brain Research Organization (IBRO)
MAIN HONORS AND AWARDS
1997 Recipient of the Theodore-Ott Prize of the Swiss Academy of Medical Sciences
2001 Elected Member of Academia Europaea
2001 Elected Member of the Swiss Academy of Medical Sciences, ad personam
2002 Recipient of the Emil Kraepelin Guest Professorship, Max Planck Institute für Psychiatry, Münich
2006 Elected Professor at Collège de France, Paris, International Chair 2007-2008
2009 Goethe Award for Psychoanalytic Scholarship, Canadian Psychological Association
2011 Camillo Golgi Medal Award, Golgi Fondation
2011 Elected Member of the American College of NeuroPsychopharmacology (ACNP)
Samuel TerrettazTeaching & PhD Courses Advanced general chemistry CH-160(f) This course aims at the acquisition of essential notions on the structure of matter, chemical equilibria and reactivity. Theoretical teaching and exercise provide the methodology to analyze and solve by reasoning and calculation novel problems of general chemistry. Advanced general chemistry CH-160(g) This course aims at the acquisition of essential notions on the structure of matter, chemical equilibria and reactivi
Julien Alexandre AndresTeaching & PhD Courses Advanced general chemistry CH-160(f) This course aims at the acquisition of essential notions on the structure of matter, chemical equilibria and reactivity. Theoretical teaching and exercise provide the methodology to analyze and solve by reasoning and calculation novel problems of general chemistry. Advanced general chemistry (for SFU) UNIL-160 The aim of this course is to acquire the essential concepts relating to the structure of matter and chemical
Nathalie JustExpertise
OncologyMRI, fMRI, fMRS, Diffusion MRS,Animal ModelsAnimal physiologyOptogenetics, Chemogenetics
Current work
-Functional magnetic Resonance imaging in rats and mice -Manganese-enhanced MRI: High Resolution MR Imaging -Functional MR Spectroscopy in small animals - New contrasts for MRI and MRS
Mission
I am interested in all functional aspects of normal and diseased brain from neural activity to metabolism.
-2011-present: EPFL-CIBM AIT Core - Responsible for MR Imaging developments and applications
Mohamed BouriDr. Mohamed Bouri is a group leader of Rehabilitation and Assistive Robotics in LSRO and lecturer of Robotics and Industrial Robotics. He graduated in Electrical Engineering in 1992 and obtained his PhD degree in 1997 in Industrial Automation at INSA LYON, France. Since 1997, he is at EPFL and is mainly active in the field of robot control, automation and robot design for medical and industrial applications. He is the head of Rehabilitation and Assistive Robotics group since 2005 and has strong references with the development of robotic devices for lower limb rehabilitation : The MotionMaker and WalkTrainer commercialzed by the company Swortec. His ongoing research currently focuses on the development of exoskeletons and the associated control strategies. His main current projects are TWIICE, a lower limb exoskeleton for people with paraplegia, AUTONOMYO, a walk assistance exoskeleton for people with muscle weakness, and the HiBSO, a hip orthosis for elderly.
Volker GassAfter completing his master’s degree in Microtechnology at the Federal Institute of Technology in Lausanne in 1989 he worked as a Project Manager at Mecanex SA, a Swiss High-Tech company active in the field of Aerospace Mechanisms. While working at Mecanex he completed a PhD in Science in the field of applied Micro-Systems Technologies at the University of Neuchâtel, Switzerland in 1994. In 1995, Volker Gass participated in the Management Buy Out of Mecanex SA. In 2000, Mecanex was acquired by the Swiss Defence and Technology group RUAG . He was appointed to lead Customer Relations and Business Development of the newly formed Systems & Space Division at RUAG Aerospace in 2004. In the same year he was appointed member of the Swiss Academy of Engineering Sciences for his contribution in the field of High-Technology Space applications. From November 2006 to June 2007, Volker Gass successfully graduated RUAG’s Top Leadership Course, and held the position of General Manager, Sales & Marketing in the Space Division of RUAG in Switzerland as well as Member of the Board of Directors (President) of Mecanex USA Inc., Berlin, CT, until December 2009.In 2008 he successfully led the acquisition of SAAB Space and its subsidiary Austrian Aerospace. From January to June 2009 Volker Gass led the business team in the successful acquisition of Oerlikon Space. From mid-2009 to September 2011 he was responsible for Special Projects in the Marketing & Sales Organization of RUAG Space Switzerland. Since October 2011, Dr. Volker Gass is nominated Director of the Swiss Space Center at the Ecole Politechnique Fédérale de Lausanne. In March 2012, he is awarded the title of Adjunct Professor at the School of Engineering (STI) of the EPFL. From January 2014 to December 2017, he was nominated member of ESA’s Human Spaceflight and Exploration Science Advisory Committee (HESAC) and from spring 2015 to December 2018, observer at ESA’s Earth Science Advisory Committee (ESAC).As of January 1, 2021, The Swiss Space Center is renamed "Space Innovation"
David Atienza AlonsoDavid Atienza Alonso is an associate professor of EE and director of the Embedded Systems Laboratory (ESL) at EPFL, Switzerland. He received his MSc and PhD degrees in computer science and engineering from UCM, Spain, and IMEC, Belgium, in 2001 and 2005, respectively. His research interests include system-level design methodologies for multi-processor system-on-chip (MPSoC) servers and edge AI architectures. Dr. Atienza has co-authored more than 350 papers, one book, and 12 patents in these previous areas. He has also received several recognitions and award, among them, the ICCAD 10-Year Retrospective Most Influential Paper Award in 2020, Design Automation Conference (DAC) Under-40 Innovators Award in 2018, the IEEE TCCPS Mid-Career Award in 2018, an ERC Consolidator Grant in 2016, the IEEE CEDA Early Career Award in 2013, the ACM SIGDA Outstanding New Faculty Award in 2012, and a Faculty Award from Sun Labs at Oracle in 2011. He has also earned two best paper awards at the VLSI-SoC 2009 and CST-HPCS 2012 conference, and five best paper award nominations at the DAC 2013, DATE 2013, WEHA-HPCS 2010, ICCAD 2006, and DAC 2004 conferences. He serves or has served as associate editor of IEEE Trans. on Computers (TC), IEEE Design & Test of Computers (D&T), IEEE Trans. on CAD (T-CAD), IEEE Transactions on Sustainable Computing (T-SUSC), and Elsevier Integration. He was the Technical Program Chair of DATE 2015 and General Chair of DATE 2017. He served as President of IEEE CEDA in the period 2018-2019 and was GOLD member of the Board of Governors of IEEE CASS from 2010 to 2012. He is a Distinguished Member of ACM and an IEEE Fellow.
Show more